Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cancers|April 13, 2023
New Automated Method for Lung Functional Volumes Delineation with Lung Perfusion PET/CT ImagingFanny Pinot, David Bourhis, Vincent Bourbonne, et al.
Frontiers in Immunology|March 13, 2026
18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitorsKarim Amrane, Coline Le Meur, David Bourhis, et al.
Scientific Reports|April 8, 2023
Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancerKarim Amrane, Philippe Thuillier, David Bourhis, et al.
Cancers|March 29, 2023
A Feasibility Study of Functional Lung Volume Preservation during Stereotactic Body Radiotherapy Guided by Gallium-68 Perfusion PET/CTFrançois Lucia, Mohamed Hamya, Fanny Pinot, et al.
Physics and Imaging in Radiation Oncology|June 11, 2025
Role of functional mapping on Gallium-68 perfusion positron emission tomography and computed tomographic imaging (PET/CT) to assess the risk of long-term radiation-induced lung toxicity after stereotactic body radiation therapyFrançois Lucia, David Bourhis, Frédérique Blanc-Béguin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2023
Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed TomographyFrançois Lucia, David Bourhis, Fanny Pinot, et al.
Radiation Oncology (London, England)|July 9, 2025
Prediction of health-related quality-of-life results after lung stereotactic body radiotherapy using dose-volume parameters from functional mapping on Gallium-68 perfusion PET/CTFrançois Lucia, Jacques Lamour, Margaux Geier, et al.
Plos One|April 3, 2026
PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocolMargaux Geier, Karim Amrane, David Bourhis, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell LymphomaVincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.
Thrombosis and Haemostasis|July 14, 2026
Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS projectFrancis Couturaud, David Jiménez, Olivier Sanchez, et al.
Pageof 6